scholarly article | Q13442814 |
P819 | ADS bibcode | 2016PLoSO..1159384B |
P356 | DOI | 10.1371/JOURNAL.PONE.0159384 |
P3181 | OpenCitations bibliographic resource ID | 4463079 |
P932 | PMC publication ID | 4956266 |
P698 | PubMed publication ID | 27441838 |
P50 | author | Johan Trygg | Q88000623 |
Thomas Moritz | Q54656435 | ||
Christian Lood | Q59692698 | ||
P2093 | author name string | Anders A Bengtsson | |
Gunnar Sturfelt | |||
Torbjörn Lundstedt | |||
Izabella Surowiec | |||
Stefan Rännar | |||
Elke Theander | |||
Dirk M Wuttge | |||
Carl-Johan Sennbro | |||
Magdalena Donten | |||
Frida Torell | |||
P2860 | cites work | Complement Components, Complement Activation, and Acute Phase Response in Systemic Lupus Erythematosus | Q72385874 |
Systemic lupus erythematosus disease activity index 2000 | Q77624632 | ||
¹H NMR-based metabolomic study of metabolic profiling for systemic lupus erythematosus | Q85049251 | ||
GC/MS-based metabolomics detects metabolic alterations in serum from SLE patients | Q95505157 | ||
Incidence studies of systemic lupus erythematosus in Southern Sweden: increasing age, decreasing frequency of renal manifestations and good prognosis. | Q50658322 | ||
Use of a microcomputer for the definition of multivariate confidence regions in medical diagnosis based on clinical laboratory profiles | Q52696296 | ||
Systemic lupus erythematosus. | Q53495545 | ||
Preliminary criteria for the classification of systemic sclerosis (scleroderma) | Q54165663 | ||
Orthogonal projections to latent structures (O-PLS) | Q56435041 | ||
The Collinearity Problem in Linear Regression. The Partial Least Squares (PLS) Approach to Generalized Inverses | Q56454402 | ||
Principal component analysis | Q56763826 | ||
OPLS discriminant analysis: combining the strengths of PLS-DA and SIMCA classification | Q58045925 | ||
Improved analysis of multivariate data by variable stability scaling: application to NMR-based metabolic profiling | Q58046047 | ||
Scleroderma (systemic sclerosis): classification, subsets and pathogenesis | Q68330753 | ||
Prolonged acetaminophen ingestion in mice: effects on the availability of methionine for metabolic functions | Q69667506 | ||
Neutrophil serine proteases: specific regulators of inflammation | Q28248366 | ||
Metabolic disturbances associated with systemic lupus erythematosus | Q28728267 | ||
The 1982 revised criteria for the classification of systemic lupus erythematosus | Q29547225 | ||
Neutrophil recruitment and function in health and inflammation | Q29616689 | ||
Chemometrics in metabonomics. | Q30359585 | ||
High-throughput data analysis for detecting and identifying differences between samples in GC/MS-based metabolomic analyses | Q31002172 | ||
Predictive metabolite profiling applying hierarchical multivariate curve resolution to GC-MS data--a potential tool for multi-parametric diagnosis | Q31043106 | ||
Visualization of GC/TOF-MS-based metabolomics data for identification of biochemically interesting compounds using OPLS class models | Q31137205 | ||
Compensation for systematic cross-contribution improves normalization of mass spectrometry based metabolomics data | Q33501801 | ||
Systemic lupus erythematosus diagnostics in the 'omics' era | Q33644106 | ||
Oxidative stress in the pathology and treatment of systemic lupus erythematosus | Q33715508 | ||
Neutrophil extracellular trap-derived enzymes oxidize high-density lipoprotein: an additional proatherogenic mechanism in systemic lupus erythematosus | Q34098294 | ||
Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group | Q34523084 | ||
Kynurenine pathway metabolites in humans: disease and healthy States | Q34633683 | ||
Informed decision-making on sympathomimetic use in sport and health | Q34751902 | ||
Type I interferon-mediated skewing of the serotonin synthesis is associated with severe disease in systemic lupus erythematosus | Q35512674 | ||
Diagnostic properties of metabolic perturbations in rheumatoid arthritis | Q35620317 | ||
Altered metabolic signature in pre-diabetic NOD mice. | Q35887965 | ||
Behavioral Deficits Are Accompanied by Immunological and Neurochemical Changes in a Mouse Model for Neuropsychiatric Lupus (NP-SLE). | Q35902490 | ||
Comprehensive metabolome analyses reveal N-acetylcysteine-responsive accumulation of kynurenine in systemic lupus erythematosus: implications for activation of the mechanistic target of rapamycin | Q36024179 | ||
Serum IL-15 in patients with early systemic sclerosis: a potential novel marker of lung disease | Q36401844 | ||
The search for lupus biomarkers | Q37308042 | ||
Chemometrics in metabolomics--a review in human disease diagnosis | Q37681808 | ||
Innate immune processes in lupus erythematosus | Q38071798 | ||
The applied basic research of systemic lupus erythematosus based on the biological omics. | Q38085206 | ||
Neuropsychiatric systemic lupus erythematosus: pathogenesis and biomarkers | Q38247180 | ||
Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee | Q39513167 | ||
Intravascular neutrophil activation in systemic lupus erythematosus (SLE): dissociation between increased expression of CD11b/CD18 and diminished expression of L-selectin on neutrophils from patients with active SLE. | Q42476015 | ||
Oxidative damage of DNA confers resistance to cytosolic nuclease TREX1 degradation and potentiates STING-dependent immune sensing | Q44535307 | ||
Systemic lupus erythematosus: a clinical analysis | Q45121430 | ||
Metabolic responses to change in disease activity during tumor necrosis factor inhibition in patients with rheumatoid arthritis | Q45733308 | ||
Extraction and GC/MS analysis of the human blood plasma metabolome | Q46849028 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 7 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | systemic lupus erythematosus | Q1485 |
lupus erythematosus | Q188297 | ||
Sjögren's syndrome | Q335555 | ||
metabolic profiling | Q116909045 | ||
P304 | page(s) | e0159384 | |
P577 | publication date | 2016-01-01 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | Metabolic Profiling of Systemic Lupus Erythematosus and Comparison with Primary Sjögren's Syndrome and Systemic Sclerosis | |
P478 | volume | 11 |
Q92633015 | A Case Report of Switching from Specific Vendor-Based to R-Based Pipelines for Untargeted LC-MS Metabolomics |
Q52620432 | Coagulation cascade and complement system in systemic lupus erythematosus. |
Q51133499 | Connective tissue diseases: Promises and challenges of metabolomics in SLE. |
Q64067989 | Fecal Metabolomics and Potential Biomarkers for Systemic Lupus Erythematosus |
Q92876537 | Identification of a Shared Microbiomic and Metabolomic Profile in Systemic Autoimmune Diseases |
Q39209701 | Immunometabolism in systemic lupus erythematosus |
Q98465680 | Immunomodulatory Effects of Diet and Nutrients in Systemic Lupus Erythematosus (SLE): A Systematic Review |
Q60047806 | Is Sjögren's syndrome dry eye similar to dry eye caused by other etiologies? Discriminating different diseases by dry eye tests |
Q92617629 | Lipidomic and metabolomic profiling reveals novel candidate biomarkers in active systemic lupus erythematosus |
Q92540366 | Machine learning applied to whole-blood RNA-sequencing data uncovers distinct subsets of patients with systemic lupus erythematosus |
Q93272085 | Metabolic Targets for Treatment of Autoimmune Diseases |
Q31143019 | Metabolic characterization of the early stage of hepatic fibrosis in rat using GC-TOF/MS and multivariate data analyses |
Q90254289 | Metabolic determinants of lupus pathogenesis |
Q55474968 | Metabolomic Profiling of Plasma Samples from Women with Recurrent Spontaneous Abortion. |
Q90014036 | Metabolomics approach reveals urine biomarkers and pathways associated with the pathogenesis of lupus nephritis |
Q41515229 | Multivariate strategy for the sample selection and integration of multi-batch data in metabolomics |
Q60907801 | Neurological and Inflammatory Manifestations in Sjögren's Syndrome: The Role of the Kynurenine Metabolic Pathway |
Q47133379 | Review: Metabolic Control of Immune System Activation in Rheumatic Diseases |
Q57034075 | Shotgun Lipidomics Revealed Altered Profiles of Serum Lipids in Systemic Lupus Erythematosus Closely Associated with Disease Activity |
Q90420055 | Significant Changes in Metabolic Profiles after Intervention with Selenium and Coenzyme Q10 in an Elderly Population |
Q39029340 | Systematic approach to understanding the pathogenesis of systemic sclerosis. |
Q64108778 | Systems Biology Approaches and Precision Oral Health: A Circadian Clock Perspective |
Q91645219 | T cell Metabolism in Lupus |
Q92712487 | T cell metabolism: new insights in systemic lupus erythematosus pathogenesis and therapy |
Q64880202 | The Influence of Diet and Obesity on Gene Expression in SLE. |
Search more.